Elbasvir + Grazoprevir

Category: Hepatitis



Elbasvir + Grazoprevir Overview

Elbasvir/grazoprevir (trade name Zepatier /zptr/ ZEP--teer) is a fixed-dose combination for the treatment of hepatitis C, containing elbasvir (an inhibitor of hepatitis C virus's NS5A protein) and grazoprevir (an NS3/4A inhibitor). It is used to treat chronic hepatitis C virus (HCV) genotypes 1 or 4 infection in both treatment-naïve and treatment-experienced patients.[1] Both elbasvir and grazoprevir were developed by Merck & Co. The US Food and Drug Administration (F...

Read more Elbasvir + Grazoprevir Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Elbasvir/grazoprevir

Recent Elbasvir + Grazoprevir Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Elbasvir + Grazoprevir
  • Tablet: 50mg + 100mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Drugs with one or more similar ingredients: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 9 May 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA